Du C, Ni M, Jiang J, Kong F, et al. Taxane/gemcitabine-containing chemotherapy plus locoregional IMRT for patients with de novo metastatic nasopharyngeal carcinoma: the treatment outcomes and prognostic factors analysis. Eur Arch Otorhinolaryngol 2022 Jan 4. pii: 10.1007/s00405-021-07192.
PMID: 34981158